Top compounds associated with response to IPO4


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0023 0.9
mRNA hyperforin CTRPv2 pan-cancer AAC 0.0024 1
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.0021 1
mRNA narciclasine CTRPv2 pan-cancer AAC -0.0018 1
mRNA Doxorubicin FIMM pan-cancer AAC 0.0075 1
mRNA SU11274 CTRPv2 pan-cancer AAC 0.0017 1
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC -0.0016 1
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.0024 1
mRNA SR-II-138A CTRPv2 pan-cancer AAC 0.0014 1
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.0023 1
Download CSV